Has Poonam Rai received payments from drug or device companies?

Yes. Drug and device makers reported $5,984 in general payments to Poonam Rai across 210 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Poonam Rai did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Poonam Rai come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Poonam Rai

Physician Assistant · Folsom, CANPI 1487297099

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,596 of the $5,984 with a category attached, or 76.8%. It is spread thinly across 55 manufacturers, the largest accounting for just 9.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,558 and has fallen 62.0% since, to $971 in 2025. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,984in general payments, 2019–2025

Across 210 payments — averaging $28.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$557
Astellas Pharma US Inc$502
Novartis$426
Seagen Inc.$410
Incyte Corporation$374
Johnson & Johnson$324
plus $3K from 49 others

What the payments were for

Food & beverage$4,59677%
Education$1,38923%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	25	$557
Astellas Pharma US Inc	9	$502
Novartis	19	$426
Seagen Inc.	8	$410
Incyte Corporation	11	$374
Johnson & Johnson	14	$324
Pfizer	8	$239
AbbVie	6	$198
Eisai Inc.	8	$195
Merck	8	$194
Sanofi-aventis U.S. LLC	2	$178
Gilead(2 entities)	3	$143
E.r. Squibb & Sons, L.L.C.	6	$143
GSK	6	$119
Puma Biotechnology, Inc.	4	$119
Regeneron Healthcare Solutions, Inc.	4	$117
Ipsen Biopharmaceuticals, Inc	4	$115
Pharmaessentia USA Corporation	4	$104
Daiichi Sankyo Inc.	3	$86
Pharmacyclics LLC, An Abbvie Company	1	$85
Array Biopharma Inc	3	$83
Amgen	4	$80
Servier Pharmaceuticals LLC	3	$80
Lilly USA, LLC	3	$75
Sobi, Inc	3	$68
Coherus Oncology, Inc.	3	$66
Takeda Pharmaceuticals U.S.A., Inc.	2	$63
Blueprint Medicines Corporation	2	$60
Mirati Therapeutics, Inc.	2	$55
Genmab U.S., Inc.	2	$49
Bayer	2	$47
Karyopharm Therapeutics Inc.	2	$45
Morphosys, US Inc.	2	$43
Genentech USA, Inc.	2	$43
EMD Serono, Inc.	2	$43
Agios Pharmaceuticals, Inc.	1	$35
Sanofi	1	$33
Bristol Myers Squibb	1	$32
Jazz Pharmaceuticals Inc.	1	$28
Stemline Therapeutics Inc.	1	$26
ADC Therapeutics America, Inc.	1	$24
Rigel Pharmaceuticals, Inc.	1	$24
Sumitomo Pharma America, Inc.	1	$24
Beone Medicines USA, Inc.	1	$24
Springworks Therapeutics, Inc.	1	$22
Foundation Medicine, Inc.	1	$22
Taiho Oncology, Inc.	1	$21
Deciphera Pharmaceuticals Inc.	1	$20
Myriad Genetic Laboratories, Inc.	1	$20
Pharmacosmos Therapeutics Inc.	1	$19
Sun Pharmaceutical Industries Inc.	1	$19
Acadia Pharmaceuticals Inc	1	$18
Organon	1	$16
AVEO Pharmaceuticals, Inc.	1	$15
Fennec Pharmaceuticals, Inc.	1	$14

How this compares

$5,984 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Acyclovir	86	$1,751
Anastrozole	106	$1,684
Letrozole	25	$1,057
Prochlorperazine Maleate	46	$506
Ondansetron Hcl	49	$455
Klor-Con-EfPotassium Bicarbonate/Cit Ac	11	$390
Dexamethasone	19	$264
Doxycycline Hyclate	11	$253
Gabapentin	47	$229
Ondansetron OdtOndansetron	11	$194
Prednisone	26	$148
Tamoxifen Citrate	18	$144
Sucralfate	11	$109
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	20	$107
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$105

Paid to pharmacies, not to this prescriber.

Other physician assistant in Folsom

Andrea NguyenIrvine$1M
Mikhail AlperMadera$889K
Erin JensenUpland$716K
Franklin ClineSacramento$458K
Carla CrespoMarina del Rey$297K
Katherine OsakiEl Centro$274K
Shawna JonesFountain Valley$266K
Heather AustinSalinas$219K
Andrea FoxStanford$172K
Asma HussainiThousand Oaks$102K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →